Exhibitors and Supporters

Agendia is a leading provider of innovative solutions in precision oncology, specializing in early-stage breast cancer. They offer reliable biological insights for personalized treatment decisions, using advanced genomic assays like MammaPrint® and BluePrint®. These assays help clinicians quickly identify the most effective treatment plan, reducing the risks of over- and under-treatment. Founded in 2003 in Amsterdam, Agendia is headquartered in Irvine, California, with a state-of-the-art laboratory. Led by world-renowned scientists and oncologists, Agendia is dedicated to advancing genomic insights through ongoing research. Notably, their FLEX Study is the world’s largest Real-World Evidence-based Breast Cancer database, aiming to revolutionize precision in breast cancer management. With cutting-edge technology, research, and innovation, Agendia strives to shape the future of precision oncology and make a significant impact in the fight against breast cancer.

American Breast Care is a leading producer of post-mastectomy products supplying: mastectomy bras, breast forms, custom prostheses, post-surgical products & accessories worldwide. At ABC, we take pride in our commitment to the amazing women that we serve. Our goal is not only to provide quality products & education, but to facilitate a positive & impactful experience in the lives of those within our reach.  From high quality, comfortable breast forms, to functional and fashionable bras to post-surgery and leisure products, ABC has the products your patients deserve and need. American Breast Care partners with retailers to bring the most innovative products to women worldwide. Interested in joining our growing ABC family? Click the following link to complete a short form: https://americanbreastcare.com/prospective-retailer/

Leading the Way in Modern Breast Care! Amoena is the world’s leading breast care brand and the developer of the first silicone breast form. Almost 50 years of experience and the strictest quality guidelines guarantee the highest product quality. To support women on their journey through breast cancer, Amoena offers product solutions that are designed to complement each other and work together perfectly. From Recovery Care to Breast Forms, Lingere & Swimwear, and Lymph Care, Amoena products are designed to support women from diagnosis to the return to their everyday lives and beyond.

Applied Medical designs, develops, manufactures and sterilizes healthcare solutions that enable advanced surgical procedures and optimize patient outcomes. We achieve this while also reducing healthcare costs and offering unrestricted choice. Applied Medical is committed to furthering minimally invasive surgery by offering sophisticated training, including workshops, symposia and our simulation-based programs.

AstraZeneca is leading a revolution in oncology with the ambition to provide cures for cancer in every form, following the science to understand cancer and all its complexities to discover, develop and deliver life-changing medicines to patients. The Company's focus is on some of the most challenging cancers. It is through persistent innovation that AstraZeneca has built one of the most diverse portfolios and pipelines in the industry, with the potential to catalyze changes in the practice of medicine and transform the patient experience. AstraZeneca has the vision to redefine cancer care and, one day, eliminate cancer as a cause of death.

AstraZeneca is leading a revolution in oncology with the ambition to provide cures for cancer in every form, following the science to understand cancer and all its complexities to discover, develop and deliver life-changing medicines to patients. The Company's focus is on some of the most challenging cancers. It is through persistent innovation that AstraZeneca has built one of the most diverse portfolios and pipelines in the industry, with the potential to catalyze changes in the practice of medicine and transform the patient experience. AstraZeneca has the vision to redefine cancer care and, one day, eliminate cancer as a cause of death.

bcalmed, Inc., a 501(c)(3) non-profit, and the bcalmed bag were created to help patients manage post-operative drains after surgical procedures such as mastectomies and lumpectomies. The bcalmed bag is provided free of charge to any patient to ease their journey to recovery.

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. bd.com

Best Medical International encompasses a family of trusted companies and organizations with a proven track record of innovation, quality, and service in external beam radiation therapy, brachytherapy, and vascular brachytherapy solutions. Best Medical International manufactures and supplies Iodine-125 and Palladium-103 seeds, needles, templates, applicators, catheters, fiducial markers, double-breast balloons, interoperative radiation therapy devices, ultrasound imaging system and probes, breast localization needles, and a variety of other products for brachytherapy and other radiation therapy applications. We aim to be the one partner clinicians turn to for all their radiation therapy and oncology product and service requirements.

Boiron, world leader in homeopathic medicines, is best known for its popular Arnicare® line of pain relievers and Oscillococcinum® flu medicine. Founded in 1932 by Jean and Henri Boiron, the company provides a full line of low-risk options to benefit consumers and health care professionals in more than 50 countries.

C2Dx is a medical device company that acquires and invests in underserved products to propel their impact worldwide. Founded in early 2019 by industry experts, C2Dx is committed to providing leading medical products and superior customer service while continually evolving to ensure that healthcare providers have the devices and technology they need.

At Cardinal Health Nuclear & Precision Health Solutions, our products and services are essential in helping support nuclear medicine providers as they care for their patients. Our portfolio of radiopharmaceuticals includes agents used in lymphatic mapping and guiding sentinel lymph node biopsies in patients with breast cancer. 

Southern Scientific has many years of experience and expertise working in the specialist health sector. Indeed, as part of the LabLogic group, the company is a key supplier to the healthcare sector worldwide. We are the manufacturer of the Care Wise C-Trak Apollo Gamma Probe System which provides accurate and precise detection of radiation for use during sentinel node biopsies in breast, melanoma and other types of cancer. The C-Trak Apollo’s distinctive feature is our superior sensitivity and directionality, but now we also offer wired or wireless connectivity with the same probe allowing for complete flexibility. Using our proven OmniProbe® technology, the Apollo offers precise and accurate detection of various isotopes. Its superior directionality means quick and accurate identification of subjects which leads to less dissection and improved procedures. Software for the C-Trak Apollo has been reimagined, with several new features including autoranging capabilities, choice of four audible signals, easier switching between isotopes (such as Tc-99m and I-125), storage of calibration tests and prompts for renewing calibration sources.

CAREstream America specializes in delivering premium solutions that are revolutionizing the surgical industry. Our innovative water-jet assisted lipoharvest technology employs a fan-shaped, pulsating jet to delicately separate adipose cells from surrounding structures and aspirates through a dual-action cannula. This proven technique not only helps to preserve adipose viability but also lowers the rate of hematomas all without the need for general anesthesia. Unlike traditional methods, our system eliminates the need for prolonged waiting periods before commencement, expediting procedures without compromising quality. The result? More natural-looking outcomes that enhance patient satisfaction and confidence. At our core, we are committed to providing breast surgeons with the tools they need to achieve exceptional results, driving forward the boundaries of reconstructive surgery. Join us in shaping the future of medical innovation!

Cirdan is a leading provider of informatics and imaging solutions that support and speed up patient diagnosis. Headquartered in the UK, with offices in Canada and Australia, Cirdan is recognised as one of the leading suppliers of laboratory information systems (LIS) worldwide. Innovation is at the heart of Cirdan, and we are committed to improving the treatment of breast cancer and helping surgeons reduce readmission rates by providing rapid and accurate imaging at the point of care for both core biopsy and surgical specimens. Our family of imaging products aid clinicians in the diagnosis of breast cancer in patients across the globe. CoreLite is our dedicated specimen x-ray cabinet designed to verify microcalcifications of breast biopsy cores. It is compact and self-contained cabinet, meaning it can be located in the biopsy room where specimens can be imaged and verified in seconds at the point of care, allowing for a significantly shorter procedure, which reduces patient anxiety and stress. Solas OR is our dedicated X-ray specimen cabinet designed for surgical and biopsy suites, providing high image quality, streamlined workflow, and reduced procedure times. Enabling clinical staff and surgeons to accurately, and securely manage patient cases as efficiently as possible. Find out more at www.cirdan.com.

Clarix Imaging brings unprecedented clarity to intraoperative lumpectomy margin visualization with our true 3D (CT) VSI-360™ Volumetric Specimen Imaging System.

Cooler Heads proudly presents Amma™, the first FDA-cleared, portable scalp cooling system tailored for chemotherapy-induced alopecia. Designed with a discreet and inconspicuous profile, Amma™ redefines patient experience through its smooth maneuverability and wholly self-administered functionality, reinstating power to the patient and promoting their natural right of privacy, agency, and identity. Amma™ pushes the boundaries of traditional scalp-cooling solutions, democratizing access to a revolutionary technology. Beyond mitigating hair loss, our innovation aims to elevate the individual's sense of self, nurture mental well-being, and improve quality of life during the treatment journey. Led by Kate Dilligan, a resilient 6-year breast cancer survivor, Cooler Heads empathetically innovates based on firsthand insights into cancer symptom management. Our mission is clear: to provide patients with widespread access to cutting-edge scalp cooling, offering a streamlined solution for patients and healthcare providers.

Extraordinary medicine, extraordinary life! For any physician, true career satisfaction requires the perfect blend of excellence, support, teamwork, and work-life balance. And you can find it all at Covenant HealthCare, named a Best-in-State Employer by Forbes magazine. For any physician, true career satisfaction requires the perfect blend of excellence, support, teamwork, and work-life balance. And you can find it all at Covenant HealthCare, named a Best-in-State Employer by Forbes magazine. Covenant HealthCare is the Great Lakes Bay Region’s largest and most preferred hospital, with more than 500 doctors on staff and 4,400 total employees. We are committed to providing extraordinary medical care to patients in more than 20 counties, through 20+ inpatient and outpatient facilities, including two major acute care medical centers.

Designs for Vision, Inc. was established in 1961 to enhance the visualization of clinical professionals through wearable magnification and illumination devices. The mission has expanded into the field of Fluorescence Guided Surgery. We are lowering the capital expense to provide FGS and making FGS available to all medical centers.

Dilon Technologies® Inc., a medical device manufacturer based in Newport News, Virginia, strives to improve the quality of care by providing a wide range of innovative medical device technology that benefits patients around the world. Dilon has a strong medical device portfolio which includes, MarginProbe®, a groundbreaking technology for accurate margin assessment in breast cancer surgery, the Navigator 2.0™ System, a surgical gamma probe system for radio-guided lymphatic mapping and tumor localization, TrueView Pro 100, a specimen radiography system (SRS) that uses advanced radiography and automated software to precisely identify tumor lesions in resected or biopsied breast tissue, and HEMOBLAST™ Bellows, the only combination powdered surgical hemostat that contains collagen, thrombin and chondroitin sulfate.

Elucent Medical has designed the EnVisio® Navigation System; a novel device that utilizes an innovative electromagnetic field and SmartClip® to enable precise stereotactic navigation within a wide field of view to a target of interest. The integration of the navigation tool onto the electrocautery device provides real-time guidance in the surgical field to deliver visual and audible indicators that provide Depth, Distance, and Direction to the SmartClip. This integrated system enables increased speed because of the ability to have the EM pad providing localization of SmartClips, in addition to the Real-Time Navigation is within the surgeon's hand. The guidance and localization update as the tissue is manipulated during the surgery. The generation of an unprecedentedly large field of the electromagnetic field for navigation, the EnVisio System, and SmartClip technology broaden the treatable patient population expanding SmartClip localization from the breast, and lymph nodes to the head and neck, abdominal soft tissue as well as the lung in the future. Elucent Medical is founded on the continued collaboration of multi-disciplinary physicians who seek to improve patient outcomes. The EnVisio Navigation system addresses the clinical need to meet the broadest patient demographics from simple (single site) to complex (several sites in the breast and axilla) cases allowing individualized treatment.

Emet Surgical is dedicated to revolutionizing cancer surgery by facilitating seamless collaboration between surgeons and pathologists, ultimately aiming to significantly reduce the need for reoperations. Our innovative approach focuses on the concept of "One and Done" cancer surgeries, where accurate tumor margin marking plays a crucial role in achieving successful outcomes. Our groundbreaking TrueMargin™ system, which is currently undergoing FDA 510(k) clearance review, we are paving the way with more precise in vivo and ex vivo tumor margin marking. This first ever approach empowers surgeons to intraoperatively, with high precision, mark tumor and excision cavity margins, thereby facilitating better communication and collaboration with pathologists. By enabling real-time feedback and collaboration between surgeons and pathologists, TrueMargin aims to minimize the likelihood of leaving residual cancer cells behind, ultimately reducing the need for reoperations. This not only improves patient outcomes and satisfaction but also results in significant cost savings for healthcare providers and insurers. Emet Surgical is headquartered in Denver, Colorado, with substantial operations located in Tel Aviv and Haifa, Israel. Medical professionals and press inquiries are encouraged to reach out to the company via email at Info@EmetSurgical.com. For investment inquiries, please visit www.StartEngine.com/Offering/EmetSurgical. Investing in securities involves risks, and potential investors should carefully review all offering materials and consult with financial advisors before making any investment decisions.

At Endomag, we believe everyone deserves a better standard of cancer care – that’s why we design our unique magnetic technologies with both the clinician and patient in mind. Many leading hospitals across the US use our solutions to help breast cancer patients avoid surgery when it isn’t needed, and experience better outcomes when it is. Our Magseed® marker is a tiny, non-radioactive seed, ideal for accurately marking tumors and lymph nodes, while the Magtrace® lymphatic tracer is the world’s first, long-lasting, non-radioactive dual tracer for lymphatic mapping. Paired with the Sentimag® localization platform, they have now been widely proven across over 100 clinical studies, featuring more than 20,000 patients. The Sentimag® platform, distributed by Mammotome in North America, has already helped 450,000+ women worldwide to access more precise and less invasive breast cancer treatment. Are you ready to join the magnetic revolution? To find out more, visit www.endomag.com

Esaote North America, Indianapolis, part of the Esaote Group, a global leader in research, production and marketing diagnostic medical equipment. Among the largest manufacturers of ultrasound systems worldwide, Esaote prides itself in achieving superior price and performance. Esaote delivers a wide range of ultrasound Imaging solutions in main women's health imaging applications from light-weight portable laptops to premium performance cart-based systems.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X (formerly known as Twitter) @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Hologic is a global medical technology company specializing in women’s health and well-being. We offer innovative solutions for screening, detecting and treating conditions and diseases that affect women throughout their lives, including breast, gynecological and skeletal issues; cervical cancer testing and sexually transmitted diseases. As a science-driven company, our products are backed by clinical evidence, ensuring that they perform as intended, so healthcare professionals can have greater certainty in their decisions and patients, greater peace of mind.

IceCure believes we must do more to improve treatment for benign and cancerous tumors. We believe in empowering both patients and their healthcare providers to expand treatment choice. We understand that patients have their own unique needs and there is no one size treatment that fits all. We believe cryoablation empowers that choice and can help turn today’s often daunting cancer treatment experience into a hopeful and restorative one. By providing outstanding results with a minimally invasive and convenient treatment experience, our ProSense Cryoablation System delivers on this promise. It’s Your Choice.

ImpediMed is a medical technology company that uses bioimpedance spectroscopy (BIS) technology to generate powerful data to maximize patient health. The SOZO® Digital Health Platform is the only FDA-cleared BIS solution for lymphedema assessment - delivering fast, non-invasive results in less than 30 seconds. Early detection and intervention of lymphedema at the subclinical level before any visible swelling is critical. Offer your patients peace of mind. Know their L-Dex® score with the leading technology for point-of-care lymphedema assessment. Learn more: www.impedimed.com

INFINITY- The world's best massage chair In today's culture, we place more emphasis on our wellness than ever before. After all, a higher level of overall well-being leads to a higher quality of life, which better equips us to conquer our limitations and enjoy doing the things we love most. At Infinity, we aim to help people of all lifestyles do just that. Our mission is to improve the health and wellness of our customers to live more comfortably and make the most of every day. Experience relaxation with INFINITY- The world's best massage chair

Innoblative is a private medical device company addressing clinical unmet needs for patients with breast cancer and other soft tissue diseases. We are developing advanced energy-based surgical solutions to help improve the way surgeons coagulate and ablate soft tissue to achieve better care for patients. Innoblative has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the company’s SIRA® RFA Electrosurgical Device. The SIRA® device is cleared for intraoperative coagulation and ablation of soft tissue. The SIRA® device is investigational for use in BCS and is not yet available for sale in the United States.

Invitae is a leading medical genetics company trusted by millions of patients and their providers to deliver timely genetic information using digital technology. We aim to provide accurate and actionable answers to strengthen medical decision-making for individuals and their families. Invitae's genetics experts apply a rigorous approach to data and research, serving as the foundation of their mission to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.

iSono Health's FDA-cleared and patented solution, ATUSA, emerges as a beacon of progress, creating a new care delivery to revolutionize breast care for millions annually. Its 3D quantitative ultrasound images use an ML engine and cloud delivery to deliver high-quality images to radiologists in additional settings than traditional radiology centers. ATUSA’s wearable (bra-like) disposables provide a personalized and comfortable patient experience. The future of healthcare is distributed with increased access to care at low cost. iSono’s platform is uniquely positioned to bring breast imaging to every woman at PoC and improve clinic labor efficiency, offering a compact and automated ultrasound system.

At KUBTEC®, our passion is developing transformative technologies that enable precision surgery for breast cancer. We are leaders in margin management technology, offering the widest range of specimen imaging systems for the OR. The MOZART iQ® System is setting a new standard of care for breast cancer surgery. It utilizes the same core technologies as leading mammography systems - 3D tomosynthesis X-ray technology and amorphous selenium direct capture imaging technology - to provide an exceptional view of surgical margins, helping surgeons confirm margin status more accurately and efficiently. MOZART 3D imaging technology has been shown to reduce re-excision rates, preserve healthy breast tissue, and improve efficiency. The PICASSO® System is the most comprehensive 2D specimen imaging system solution available, with high image quality, a large active imaging area, and all the same proprietary workflow features found in Mozart iQ that are designed to improve OR efficiency. In addition to specimen imaging systems, we also offer GammaPRO® - a modern, highly innovative gamma detection system optimized for today’s fast-paced clinical environment. The unique crystal technology at the heart of GammaPRO® is a pivotal advancement in probe design that sets a new standard for sensitivity and reliability. Its narrow tip, ease of use and maneuverability make GammaPRO® ideal for precision surgery. It is also the world’s first and only gamma probe to be fully integrated with intraoperative specimen imaging systems. Contact us to learn more about our innovative technologies.

Legally Mine forewarns and forearms medical professionals against facing potential legal liability. Legally Mine will show you how to stop the threat of lawsuits before they ever get started by protecting your assets in time tested and proven legal structures. These same structures allow our tax attorneys to help you save what you would normally pay in income taxes. These are little known tax helps that have significant case history and have stood the test of time.

Lumicell is transforming the way you see breast cancer surgery. Our investigational fluorescence imaging technology is designed to illuminate residual breast cancer in real time. The system is pending FDA approval for use in patients with breast cancer to assist in the detection of cancerous tissue within the lumpectomy cavity following removal of the primary specimen during lumpectomy surgery.

At Mammotome, we are a global team dedicated to advancing breast care. Our passion is driving innovative technologies that create efficiencies for clinicians, while never forgetting that at the heart of every breast cancer journey is a patient.

Maple Tree is the leading provider of exercise oncology in the world. We partner with hospitals, fitness centers, and universities across the globe to improve the quality of lives for individuals battling cancer. We accomplish this through our evidence-based, individualized exercise programs.

Masthead® was launched in 2012 by a physician who was also a mastectomy patient. Her personal and professional experience gave her the most intimate knowledge of the challenges post-op recovery can present, enabling her to create solutions that are second to none. Owned by women with decades of experience in medicine, design, and performance materials, Masthead provides state-of-the-art products and exceptional customer service at every step of your patients’ journeys. The top hospitals in the country provide our state-of-the-art flagship Elizabeth Pink Surgical Bra®—also known as “the pink one,” to their patients. By listening to and working with leading clinicians in the field from all over the world, we’ve been able to continuously update current products and design important new ones to meet the evolving surgical techniques and clinical trends. We at Masthead® have guided hundreds of thousands of women from diagnosis through recovery. Helping you provide the best care to your patients is our mission.

At Merck, our goal is to translate breakthrough science into innovative oncology medicines to help people with cancer. The potential to bring new hope to people with cancer drives our purpose and our commitment. As part of our focus on cancer, Merck is committed to clinical research with one of the largest development programs in the industry across more than 30 tumor types.

Merit Oncology is on a mission to reduce the burden cancer places on patients and their loved ones. As a provider of world class solutions for the diagnosis, localization, and treatment of cancer, Merit Oncology consistently invests in improving our technologies and innovating new platforms to meet our physicians' needs. The preferred localization solution to treat more patients, the SCOUT® Radar Localization system has been clinically proven in over 500,000 breast and soft tissue localizations and is referenced in over 90 clinical publications. The technology represents unparalleled accuracy, can be placed under all imaging modalities, and will not interfere with imaging interpretation, including MRI. It is uniquely suited to be placed at any time prior to surgery, including prior to neoadjuvant chemotherapy. The SCOUT system has been clinically demonstrated to improve patient outcomes, workflow and significantly reduce OR delays. Easing the burden of breast cancer treatment, SAVI® Brachy offers a strut-based approach to tissue-sparing dosimetry and is designed to maximize ease of use during placement while providing unparalleled dose customization. Three-fraction treatment protocol with SAVI allows effective APBI treatment to be completed in as little as 2 days, sparing healthy tissue and significantly reducing patient treatment time.

Mitaka's microsurgery solutions are built for the surgeon who is dedicated to performance. Surgeons never stop improving their skills, and Mitaka never stops working with innovative partners to improve its products. With the same level of precision, Mitaka works to meet the needs of customers proactively so that they can focus on what really matters. You need world-class tools for a world-class job. You need a partner who can match your dedication--a dedication to performance. Founded in 1997 by Max Sturgis, Mitaka USA, Inc. is focused on developing new technologies in the fields of microscopic, fluorescent, and 3D surgical imaging.

MOLLI Surgical started with one patient’s voice — a patient who asked if there was a way to make her breast cancer journey better. Her voice led to the creation of our flagship wire and radiation-free technologies — MOLLI 2® and MOLLI re.markable™. Our innovations are intended to replace outdated procedures to mark lesions for surgical removal with greater precision, efficiency, and cost-effectiveness. We are obsessed with every detail of our design process to ensure surgeons and radiologists have the best possible tools in their hands to support an improved patient experience. MOLLI® has been recognized by TIME as one of 2022’s “Best Inventions” in the Medical Care category and named to Fast Company’s list of the “Next Big Things in Tech,” recognizing technology breakthroughs across industries that promise to transform the future. We are proud to build the advanced solutions that patients and physicians prefer.

Myriad Genetics is a leader in genetic testing and precision medicine advancing health and well-being for all and helping healthcare providers better detect, treat and prevent disease.

Signatera™ for Breast Cancer Personalized, tumor-informed ctDNA molecular residual disease (MRD) testing for breast cancer to inform critical decisions for care.

Northside Hospital system is nationally recognized for expertise in Cancer Care, Maternity Services, Radiology, Surgery and Women's Health. Our system includes 5 non-for-profit, acute-care hospitals and over 250 hospital affiliated outpatient centers and medical office buildings throughout the Atlanta Region. Our more than 3,900 providers on staff and more than 24,000 employees serve more than 4 million patients annually.

Not Putting on a Shirt is a nonprofit organization advocating for optimal surgical outcomes for women going flat after mastectomy. Visit our website (www.NotPuttingonaShirt.org) to access free resources about aesthetic flat closure for patients and providers, including medically reviewed information, brochures, and a flat friendly surgeons directory, or to learn more about our programs and institutional initiatives.

obp is the leading global developer of single-use, self-contained, illuminating surgical devices. We integrate light with device — making them one — creating effective and simplified single-use solutions.

OncoLens is a cancer-focused, multi-disciplinary treatment planning platform used by more than 200 U.S. Cancer Centers. For Providers, the platform enables data interoperability, AI driven informatics and collaboration. Care teams are empowered to identify potential gaps in care, patients for clinical trials or specialized services, operational/clinical metrics, and drive efficiency throughout the treatment lifecycle.

OSF HealthCare is an integrated health system owned and operated by The Sisters of the Third Order of St. Francis, headquartered in Peoria, Illinois. OSF HealthCare has 16 hospitals – 10 acute care, five critical access, one transitional care - with 2,131 licensed beds throughout Illinois and Michigan. OSF employs nearly 24,000 Mission Partners across 150+ locations; has two colleges of nursing; operates OSF Home Care Services, an extensive network of home health and hospice services; owns Pointcore, Inc., comprised of health care-related businesses; OSF HealthCare Foundation, the philanthropic arm for the organization; and OSF Ventures, which provides investment capital for promising health care innovation startups. In 2020, OSF OnCall was established, a digital health operating unit, including a hospital-at-home. OSF OnCall delivers care and services when, where and how patients prefer to receive them. OSF HealthCare has been recognized by Fortune as one of the most innovative companies in the country. More at osfhealthcare.org/.

Pacira BioSciences, Inc. (Nasdaq: PCRX) is committed to providing non-opioid options to as many patients as possible to redefine the role of opioids as rescue therapy only. Pacira has three commercial-stage non-opioid options for treating pain: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesic approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, injection indicated for the management of osteoarthritis knee pain; and ioveraº®, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. To learn more about Pacira, visit www.pacira.com.

Perimeter Medical Imaging AI is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools that address unmet medical needs. Based in Toronto, with U.S. headquarters in Dallas, Texas, Perimeter aims to harness the power of big data, artificial intelligence, and machine learning technology to further its mission of improving the standard of care, providing better long-term outcomes for patients, and reducing healthcare costs. Available now across the U.S., Perimeter’s S-Series OCT, powered by Optical Coherence Tomography, is designed to visualize tissues at the cellular level during surgical procedures, rather than days later when pathology reports come back. Our FDA-cleared technology gives surgeons cross-sectional visualization of surgical margins and excised tissues in real time, with 10x higher image resolution than standard X-ray and ultrasound, and 100x greater than MRI. Our next-generation technology will use ImgAssist AI, a powerful artificial intelligence and machine learning tool designed to assist surgeons with visualizing margins. In November 2021, Perimeter received FDA Investigational Device Exemption (IDE) approval and launched a multi-site, randomized clinical trial using Perimeter B-Series OCT with ImgAssist AI. The study evaluates this system against the current standard of care and assesses the impact on re-operation rates for patients undergoing breast conservation surgery. For more information, visit www.perimetermed.com

Comprised of 23 hospitals, more than 3,500 employed physicians, and over 1600 physician and specialist offices across greater Atlanta and North Georgia, Piedmont Healthcare is a fast-growing, recognized leader in delivering high quality care. Metro Atlanta’s vibrant economy fuels a wealth of global communities and diverse cultural experiences, while the state of Georgia offers coastline beaches and mountain views. Live and work with the best at Piedmont in the big and small towns of the Peach State.

PreludeDx is the leading personalized breast cancer diagnostics company dedicated to improving outcomes for patients diagnosed with DCIS (Ductal Carcinoma in Situ). The company provides patients and physicians with evidence-based tools to improve patient outcomes and reduce the cost to the healthcare system by helping to ensure women are not over or under treated. For women diagnosed with DCIS, PreludeDx provides a patented molecular test (DCISionRT®) that predicts a woman’s personal likelihood or risk of developing DCIS recurrence in 10 years and invasive breast cancer in 10 years with or without adjuvant radiation therapy after breast conserving surgery. Visit PreludeDx.com

Breast and General Surgery Private Practice seeking to hire fellowship-trained breast surgeons and surgical oncologists for our partner practices across the nation.

RecoverEasy serve the needs of surgery recovery patients with novel products designed to promote wound healing, improve quality of life, and enhance emotional well-being.

Losing one or both breasts can be overwhelming—it’s why many women choose reconstructive surgery. But one thing you may not be aware of is that after a mastectomy and even reconstruction, women can experience anywhere from partial to complete numbness in their chest. With Resensation you have the opportunity to not only look—but potentially feel—more like yourself again. This surgical technique has the potential to restore sensation to your breast as part of breast reconstruction.

RICOH 3D for Healthcare is an integrated end-to-end workflow solution that makes the production of patient-specific 3D-printed anatomic models simple, fast and accurate. Now, any medical facility can provide their teams with cost effective 3D printing services that work with existing platforms to serve the needs of patients and providers alike. At Ricoh, we unlock the power of information so organizations can unlock the full potential of their people. At Ricoh, there's no such thing as TMI. Find out how Ricoh 3D for Healthcare can work for you.

Ronin Surgical Corp. -- makers of industry-leading operating room headlight systems. Our products are the lightest, brightest and longest-running on the market. Contact Ronin at +1.415.226.9414 or Contact@RoninSurgical.com. Ronin Surgical: Designed Without Compromise. www.RoninSurgical.com

Silbiotech, Inc., featuring the BBDRisk Dx® Test. The BBDRisk Dx® Test (Benign Breast Disease Risk) is a new tumor biology based genomic test designed to address the dilemma in treating atypical hyperplasias. Studies show that ~20% of atypical patients develop cancer. The BBDRisk Dx® Test assesses multiple cancer markers in FFPE atypical tissues by IHC, generates a ‘Risk Score’ from 0-10 and categorizes the patient into a Low, Intermediate or High Risk group. Cancer rates in the low risk group are less than 3% over 15 years. Cancer rates in the high risk group are 75% in the first five years after atypia diagnosis. In the intermediate group cancer rates are less than 20% over 15 years. BBDRisk Dx® was validated in 550 clinical samples. BBDRisk Dx® offers for the first time assessment of a patient’s personalized risk level. Clinicians can now make informed treatment decisions in managing atypias.

SimBioSys is a pioneering TechBio company leveraging artificial intelligence and biophysical modeling to harness the power of spatial biophysics to redefine precision medicine, transform patient care and defeat cancer. By seeing cancer more completely, SimBioSys aims to empower clinicians and researchers with a more informed understanding of a patient’s tumor to optimally assess all available options and deliver on the promise of truly individualized patient care. To learn more, visit us at https://www.simbiosys.com/.

About Sirius Medical With its roots deeply embedded in the Netherlands Cancer Institute, Sirius Medical is dedicated to improving care for cancer patients by delivery of unsurpassed, yet affordable solutions that enable precise and efficient removal of tumors. The Pintuition technology is precise, simple, affordable and both CE marked, and FDA cleared for long term implant and soft tissue placement. Sirius Medical is rapidly expanding with over 19,000 procedures worldwide in over 200 centers combined with a global commercial network covering the USA, Western Europe and Australia-New Zealand.

3M Health Care is now Solventum! We focus on providing better care through patient-centered science. Helping transform outcomes by restoring patients’ lives through innovation. From our leading negative pressure and surgical incision management technologies to our comprehensive line of skin and advanced wound care solutions, we are focused on helping you provide the best care for your patients, resulting in the best possible outcomes.

As a leader in minimally invasive surgery, Stryker offers comprehensive solutions to meet the changing needs of the high-tech operating room. Our long history of innovation and constant development in advanced imaging and OR connectivity is driven by our desire to help healthcare professionals to see and do more. Through our first-class services and technologies, we are committed to our customers and to helping them achieve the best possible surgical outcomes.

Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency, and chronic pulmonary disease by helping them live better and care for themselves at home. The company collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.

Terason, a division of Teratech Corporation began in 1994, drawing upon technology perfected at MIT’s Lincoln Laboratory. Dr. Alice Chiang founded the company to apply developments in the fields of radar, sonar and telecommunications technologies to the demanding requirements of battlefield ultrasound. Recognizing that decades of breakthrough research for the Department of Defense could be applied to the challenges of mainstream ultrasound imaging, Dr. Chiang formed the Terason division. With initial key patents protecting the integrated circuit technology she developed at MIT, Dr. Chiang dedicated the Terason division to the development of a micro-miniaturized commercial ultrasound system. Having delivered on the promise of high performance micro-miniaturization, Terason has shipped thousands of ultrasound systems to clinicians, hospitals, outpatient centers and OEM partners since 2000. Terason is the market leader in breast ultrasound. We are also successful in various other markets including cardiology, musculoskeletal (MSK), vascular surgery, interventional radiology, endocrinology and breast surgery.

The ACS Cancer Programs provide tools, resources, and data that enable cancer programs to deliver comprehensive, high-quality, multidisciplinary, evidence-based, patient-centered care to patients with cancer and diseases of the breast.

The American Society of Breast Surgeons, the primary leadership organization for surgeons who treat patients with breast disease, is committed to continually improving the practice of breast surgery by serving as an advocate for surgeons who seek excellence in the care of breast patients. Stop by our booth to learn more about the Society’s programs and services, renew or update your membership, peruse our Society Swag store, and engage in informative discussions. We look forward to seeing you!

The US Oncology Network believes local cancer care is better care. We empower the delivery of advanced integrated cancer care through our network of independent physicians who share expertise and resources to provide quality, value-based care close to home.

Thompson Retractor, sole manufacturer of the table-mounted Thompson Retractor, is dedicated to supporting surgeons in their journey to pursue successful patient outcomes (innovatively) around the world! With a rich history spanning over 55 years, Thompson has earned a reputation for providing strong, stable, and reliable exposure to a variety of surgical specialties. The Thompson Retractor is designed with surgeon input to provide Uncompromised Exposure. As a trusted partner, Thompson Retractor empowers surgeons to deliver the highest quality care with confidence and precision. Visit our website at www.thompsonretractor.com to explore our comprehensive range of retractors and experience the future of surgical excellence.

Vector Surgical is the global leader in tissue orientation devices that provide the most accurate designation of excised tissue margins in cancer surgery. Our devices integrate the needs of surgeons, pathologists and radiologists, providing unparalleled tools that enable the highest level of care for their cancer patients. Leading hospitals and physicians are eliminating error and supporting successful surgical outcomes from the OR through recovery with Vector Surgical's Tissue Orientation System: MarginMarker™ sterile ink kit, CorrectClips™ radiographic markers and the SilversteinWrap™. Vector Surgical's innovative devices deliver: • More accurate re-excisions • Fewer unnecessary re-excisions • Lower cancer recurrence • Reduction in post-surgical complications • Improved cosmesis

Videra Surgical is an oncology surgery company focused on breast cancer treatment with the VeraForm® marker. We strongly believe that helping radiation oncologists better identify the tumor bed is essential for the continuum of care for breast cancer patients. VeraForm is an adaptable tissue marker comprised of a radiopaque filament that provides a continuous, 3-dimensional, multi-plane and permanent mark of a tumor bed. VeraForm is easily viewed by the radiation oncologist under X-ray and CT/CBCT, but it does not create artifact in MRI or ultrasound, as it is completely metal-free. VeraForm is 510(k) cleared and has been placed in thousands of patients in a rapidly growing number of U.S. centers. VeraForm is designed to provide a precise depiction of the tumor bed, allowing radiation oncologists to be more targeted in the delivery of radiation, in an attempt to avoid over-radiating and possibly damaging collateral tissue and organs.

XEOS is focused on improving outcomes in surgical oncology by leveraging the power of molecular imaging in the operating room. The company’s AURA 10 specimen PET-CT imager provides surgeons with an immediate 3-dimensional visualization of the resected tissue specimen at the point of surgery. This information helps the surgeon ensure that a complete resection is obtained. Promising results have been obtained in breast surgery.

The medical technology business of ZEISS offers future-oriented technologies for intraoperative radiotherapy. The INTRABEAM system, which can be managed by a single radiation oncologist, enables a targeted, risk-adapted and interdisciplinary treatment of tumors. A shortened overall treatment regime can reduce associated side-effects and enhance the comfort of the treatment for the patient.